5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer
US10561653B2 · kind B2 · utility
9Cited by
4References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 10, 2016 |
| Grant date | Feb 18, 2020 |
| Priority date | — |
| Expiry date | Oct 8, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to 5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine, its pharmaceutically acceptable salts and co-crystals thereof and to pharmaceutical compositions comprising said compounds for use in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.